Work

177P Organ specific tumour response to first-line (1L) therapy with combined lenvatinib (LEN) and anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma (HCC)

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.10.198

Authors: H-C. Sun, C. Huang, X-D. Zhu, Y-H. Shen, D. Wu, N-L. Ge, Y. Chen, C-J. Tan, J. Zhou, J. Fan

Institutions: Fudan University, Zhongshan Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Government of Jiangsu Province

Award: G3634861042

OpenAlex ID: W3107075415

FWCI: 0.149

Cites:

Cited by: 1

Related to: 10